Institution Directory

Clinical trials at Cedars-Sinai Medical Center

Sites in Los Angeles, CA

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 12:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

664

Shown on this page

Current sort

Live official records

Conditions: Aortic Stenosis Symptomatic
Interventions: Siegel Transcatheter Aortic Valve (TAVR); Device
Lead sponsor: MiRus; Industry
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 8
States / cities: Los Angeles, California • Palo Alto, California • Naples, Florida + 5 more

Conditions: Pain and Anxiety
Interventions: VR Guided Meditation; Device
Lead sponsor: Christopher Almario; Other
Eligibility: 18 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Osteochondral Defect
Interventions: osteochondral transplant on the femoral condyle; Procedure
Lead sponsor: AlloSource; Industry
Eligibility: 12 Years to 60 Years
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 6
States / cities: Phoenix, Arizona • Los Angeles, California • Redwood City, California + 3 more

Conditions: Tricuspid Regurgitation
Interventions: Transcatheter Tricuspid Valve Replacement; Device
Lead sponsor: Trisol Medical; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2031
U.S. locations: 7
States / cities: Los Angeles, California • Atlanta, Georgia • New York, New York + 4 more

Conditions: Heart Failure
Interventions: OPTIMIZER Smart System; Device
Lead sponsor: Impulse Dynamics; Industry
Eligibility: 18 Years and older
Enrollment: 620 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 90
States / cities: Mesa, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 69 more

Conditions: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Balixafortide, Cosibelimab; Drug
Lead sponsor: Arsen Osipov; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anxiety, Supportive Care in Cancer, Depression
Interventions: Living Well Program; Device
Lead sponsor: Scott A. Irwin, MD, PhD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Kidney Transplantation in Highly Sensitized Patients
Interventions: Imlifidase administered in the ConfIdeS study, Best available treatment administered in the ConfIdeS study; Drug · Other
Lead sponsor: Hansa Biopharma AB; Industry
Eligibility: Not listed
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 14
States / cities: Birmingham, Alabama • Los Angeles, California • Chicago, Illinois + 9 more

Conditions: Acute Pancreatitis
Interventions: Not listed
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years to 75 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 13
States / cities: Los Angeles, California • Stanford, California • Gainesville, Florida + 8 more

Conditions: Aortic Valve Stenosis
Interventions: TAVR with CENTERA THV; Device
Lead sponsor: Edwards Lifesciences; Industry
Eligibility: Not listed
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2030
U.S. locations: 23
States / cities: Los Angeles, California • Stanford, California • Loveland, Colorado + 19 more

Conditions: Idiopathic Pulmonary Fibrosis
Interventions: Zinc, Placebos for zinc and nicotinamide riboside, Nicotinamide riboside; Drug · Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 50 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Interventions: Biospecimen Collection, Carboplatin, Cyclophosphamide, Docetaxel, Doxorubicin, Paclitaxel, Pembrolizumab, Quality-of-Life Assessment, Questionnaire Administration, Surgical Procedure; Procedure · Drug · Biological + 1 more
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 18 Years and older
Enrollment: 2,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2033
U.S. locations: 955
States / cities: Birmingham, Alabama • Anchorage, Alaska • Fairbanks, Alaska + 654 more

About this Cedars-Sinai Medical Center institution page

What this page lists: ClinicalTrials.gov records that list Cedars-Sinai Medical Center in Los Angeles, CA as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Cedars-Sinai Medical Center

Filter and sort this campus

Live official records

Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study

VR AI Meditation for Pain

Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment of Osteochondral Lesions in the Knee

Trisol System EFS Study

Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma

Living Well Program: Impact on Healthcare Costs and Clinical Outcomes in Breast Cancer Care

Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys

Diabetes RElated to Acute Pancreatitis and Its Mechanisms

ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis

Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

About this Cedars-Sinai Medical Center institution page